Electrophysiology study and catheter ablation
Wires placed inside the heart find the exact spot where an abnormal rhythm starts, and a small burn or freeze there can cure it.
Quick facts
- Key signs
- Palpitations · Fatigue
- Diagnosis
- Study
Red flags ↓
No doses: the clinician sets them by the current guideline.
What it is
An electrophysiology (EP) study threads electrode catheters through veins into the heart to record its electrical activity, measure conduction and deliberately trigger arrhythmias to find their source. Catheter ablation then destroys that small source or pathway with heat (radiofrequency), cold (cryoablation) or pulsed electric fields.
Who gets it
Ablation is an early or first-line treatment for many supraventricular tachycardias and an established option for atrial fibrillation and ventricular tachycardia. Procedures are done in an electrophysiology lab under sedation (general anaesthesia for pulsed field ablation), last from about an hour to several hours, and many patients go home the same day or the next.
Causes
- Recurrent supraventricular tachycardia (AV nodal reentry, accessory pathways) when drugs fail or are not wanted
- Wolff-Parkinson-White syndrome
- Typical atrial flutter and focal atrial tachycardia
- Symptomatic atrial fibrillation after failed rhythm-control drugs, and AF with heart failure with reduced ejection fraction
- Ventricular tachycardia refractory to drugs, often scar-related after infarction, and idiopathic outflow-tract VT
- Unexplained syncope or palpitations, and estimating the risk of sudden death
- Deciding whether a pacemaker or ICD is needed, or whether a drug controls the rhythm
- Rapid AF that cannot be controlled otherwise: AV node ablation after a pacemaker is implanted
Risk factors
- Complex left-sided procedures (AF and VT ablation)
- Structural heart disease and heart failure
- Older age and anticoagulation (bleeding, stroke)
- Ablation close to the AV node or His bundle (heart block)
Pathophysiology
Catheters record signals from the atrium, the His bundle and the ventricle, so conduction through the AV node and the His-Purkinje system can be timed. Programmed stimulation (paced extra beats) and drugs induce the tachycardia; activation mapping shows where it starts or which circuit it uses, and three-dimensional mapping systems build an electrical map of the chamber. Radiofrequency energy heats and kills a small area of tissue (up to about a centimetre wide and deep); cryoablation freezes it; pulsed field ablation opens pores in cell membranes without heat. In AV nodal reentry the slow pathway is targeted; in WPW the accessory pathway on the AV ring; in typical flutter a line of block across the cavotricuspid isthmus; in AF the pulmonary veins, where most triggers arise, are electrically isolated from the left atrium; in scar-related VT the channels of surviving muscle inside the scar.
Classification
- Diagnostic EP study alone
- Ablation of reentrant SVT: AV nodal reentry (slow pathway) and accessory pathways
- Cavotricuspid isthmus ablation for typical flutter; focal atrial tachycardia ablation
- Pulmonary vein isolation for AF
- VT ablation: idiopathic outflow-tract VT, bundle branch reentry, scar-related VT
- AV node ablation with permanent pacing (rate control, not rhythm control)
- By energy: radiofrequency, cryoablation, pulsed field
Symptoms and signs
- Palpitations or light-headedness when the rhythm is induced during the study
- Fatigue, mild chest discomfort and skipped beats for a few days afterwards
- Soreness or bruising at the groin or neck
Diagnosis
- Clinical
- The indication comes from a documented rhythm: an ECG during symptoms, ambulatory monitoring or a pre-excited resting ECG. The study confirms the mechanism before any energy is delivered.
- Tests
- Baseline conduction intervals (atrium to His, His to ventricle), sinus and AV node function, programmed atrial and ventricular stimulation to induce the arrhythmia, drug provocation, activation mapping; after ablation, re-testing proves the target is gone (tachycardia no longer inducible, block across the line, veins isolated). Before the study: kidney function, coagulation and an anticoagulation plan.
- Imaging
- Fluoroscopy guides the catheters; three-dimensional electroanatomical mapping cuts radiation; intracardiac or transoesophageal echocardiography guides transseptal puncture and excludes left atrial thrombus before AF ablation; CT or MRI defines pulmonary vein anatomy or ventricular scar.
Differential diagnosis
- Supraventricular tachycardia with aberrant conduction versus ventricular tachycardia
- AV nodal reentry versus accessory-pathway tachycardia versus focal atrial tachycardia
- Typical (isthmus-dependent) versus atypical atrial flutter
- Arrhythmic syncope versus reflex syncope
Which ablation for which rhythm?
| Rhythm | Mechanism | Ablation target | What to expect |
|---|---|---|---|
| AV nodal reentrant tachycardia | Loop through a fast and a slow pathway in the AV node | Slow pathway | Cure in over 90%; small risk of heart block |
| Accessory pathway (WPW) | Loop through an extra AV connection | The pathway on the mitral or tricuspid ring | Cure in over 90%; removes the danger of pre-excited AF |
| Typical atrial flutter | Large loop around the tricuspid valve | Line across the cavotricuspid isthmus | Success over 90%; AF may still appear later |
| Atrial fibrillation | Triggers from the pulmonary veins plus diseased atrium | Isolation of the pulmonary veins | Success about 60 to 80%, more complications; anticoagulation follows stroke risk |
| Scar-related ventricular tachycardia | Loop through surviving muscle in an infarct scar | Channels inside the scar | Sometimes successful when drugs fail; highest risk |
Goal of treatment
Prove the mechanism, then destroy the smallest piece of tissue that sustains the arrhythmia while sparing normal conduction.
Treatment
- Procedure
- Diagnostic EP study through the femoral (sometimes neck) veins under sedation; pacing and drug provocation to induce and map the arrhythmia.
- Procedure
- Catheter ablation with radiofrequency, cryoablation or pulsed field energy: slow pathway (AVNRT), accessory pathway (WPW), cavotricuspid isthmus (typical flutter), pulmonary vein isolation (AF), scar channels or focus (VT and ventricular ectopy).
- Procedure
- AV node ablation after a permanent pacemaker is implanted, for rapid AF that cannot be controlled any other way; the patient then depends on the pacemaker.
- Medical
- Anticoagulation around AF ablation and long term afterwards according to stroke risk, not according to whether the ablation seems to have worked.
- Follow-up
- Bed rest and rhythm monitoring after the procedure, access-site checks, then ECG or ambulatory monitoring for recurrence. Nursing: puncture-site and distal pulse checks, watching for hypotension (tamponade) and neurological change.
Complications
- Access-site bleeding and vascular injury
- Cardiac perforation and tamponade
- Stroke or other embolism, mainly with left-sided ablation
- Unintended complete heart block needing a pacemaker
- Pulmonary vein stenosis or occlusion after AF ablation
- Valve damage and, rarely, coronary artery or nerve injury
- Recurrence of the arrhythmia, more often after AF ablation
Common traps
- An EP study is only a diagnostic test: the same session usually goes on to ablation, or to a pacemaker or ICD decision
- AF ablation burns away the cause of AF: it electrically isolates the pulmonary veins, where most triggers arise, and succeeds less often than SVT ablation
- A successful AF ablation means anticoagulation can stop: the decision follows stroke risk, not the rhythm after ablation
- AV node ablation cures AF: the atria keep fibrillating; it only blocks the fast conduction, and the patient now depends on a pacemaker
- AVNRT ablation targets the fast pathway: the slow pathway is targeted, which keeps the risk of complete heart block low
Prognosis
For reentrant SVT, accessory pathways and typical flutter, success exceeds 90%, major complications occur in about 0.5 to 1% and death is very rare. Pulmonary vein isolation for AF succeeds in about 60 to 80% with a higher complication rate, and complex VT ablation has major complications in about 5%.
Prevention
- Excluding left atrial thrombus and planning anticoagulation before left-sided ablation
- Careful mapping and energy choice near the AV node and phrenic nerve
- Re-testing at the end of the procedure to confirm the target is gone, which lowers recurrence
Test yourself
Think of the answer, then tap the question to see it.
What is the ablation target in typical atrial flutter?
A line of block across the cavotricuspid isthmus, the strip of atrium between the tricuspid annulus and the inferior vena cava.
Why does AF ablation succeed less often than ablation of AV nodal reentry?
AVNRT depends on one circuit that can be cut; AF comes from many triggers and diseased atrium, so the veins are isolated rather than a single circuit destroyed.
Which pathway is ablated in AV nodal reentrant tachycardia, and why?
The slow pathway: cutting it breaks the loop while the fast pathway keeps conducting, so the risk of complete heart block stays low.
What must be in place before AV node ablation for uncontrolled AF?
A permanent pacemaker, because ablating the AV node produces complete heart block.
A patient becomes hypotensive with distended neck veins after ablation. What complication is suspected?
Cardiac perforation with tamponade; urgent echocardiography and pericardial drainage.
Connections
Educational information, not medical advice. For any symptom, see a health professional.
Sources: Intracardiac electrophysiology study (EPS) (MedlinePlus, US National Library of Medicine, 2026); Cardiac ablation procedures (MedlinePlus, US National Library of Medicine, 2026); Ablation for Cardiac Arrhythmia (MSD Manual Professional Edition, 2026); Atrial Fibrillation (MSD Manual Professional Edition, 2026); Atrial Flutter (MSD Manual Professional Edition, 2026).
Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake
Representative model, for educational purposes only.

